EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 12 (Décembre 2021) Med Sci (Paris), 37 12 (2021) 1158-1165 Références
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 12, Décembre 2021
Vésicules extracellulaires
Page(s) 1158 - 1165
Section Vésicules extracellulaires
DOI https://doi.org/10.1051/medsci/2021208
Publié en ligne 20 décembre 2021
  1. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018 ; 7 : 1535750. [CrossRef] [PubMed] [Google Scholar]
  2. Kim D-K, Lee J, Simpson RJ, et al. EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin Cell Dev Biol 2015 ; 40 : 4–7. [CrossRef] [PubMed] [Google Scholar]
  3. Pang B, Zhu Y, Ni J, et al. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis. Theranostics 2020; 10 : 2309–26. [CrossRef] [PubMed] [Google Scholar]
  4. Angelot F, Seillès E, Saas P, et al. Les microparticules endothéliales — Un signal d’alarme pour le système immunitaire ? Med Sci (Paris) 2010 ; 26 : 31–33. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Saint-Pol J, Gosselet F. Petits mais costauds — Les exosomes neuronaux contrôlent l’intégrité vasculaire cérébrale. Med Sci (Paris) 2018 ; 34 : 303–306. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Strimbu K, Tavel JA. What are Biomarkers? Curr Opin HIV AIDS 2010 ; 5 : 463–466. [CrossRef] [PubMed] [Google Scholar]
  7. Welsh JA, Holloway JA, Wilkinson JS, et al. Extracellular Vesicle Flow Cytometry Analysis and Standardization. Front Cell Dev Biol 2017 ; 5 : 78. [CrossRef] [PubMed] [Google Scholar]
  8. Boulanger CM, Dignat-George F. Microparticles: an introduction. Arterioscler Thromb Vasc Biol 2011 ; 31 : 2–3. [CrossRef] [PubMed] [Google Scholar]
  9. Nozaki T, Sugiyama S, Koga H, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009 ; 54 : 601–608. [CrossRef] [PubMed] [Google Scholar]
  10. Amabile N, Guérin AP, Tedgui A, et al. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant 2012 ; 27 : 1873–1880. [CrossRef] [PubMed] [Google Scholar]
  11. Suades R, Padró T, Crespo J, et al. Liquid Biopsy of Extracellular Microvesicles Predicts Future Major Ischemic Events in Genetically Characterized Familial Hypercholesterolemia Patients. Arterioscler Thromb Vasc Biol 2019 ; 39 : 1172–1181. [CrossRef] [PubMed] [Google Scholar]
  12. Sarlon-Bartoli G, Bennis Y, Lacroix R, et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol 2013 ; 62 : 1436–1441. [CrossRef] [PubMed] [Google Scholar]
  13. Lane RE, Korbie D, Hill MM, et al. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med 2018 ; 7 : 14. [PubMed] [Google Scholar]
  14. Zhou E, Li Y, Wu F, et al. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy. EBioMedicine 2021; 67 : 103365. [CrossRef] [PubMed] [Google Scholar]
  15. Wang H, Jiang D, Li W, et al. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma. Theranostics 2019 ; 9 : 5347–5358. [CrossRef] [PubMed] [Google Scholar]
  16. Roca E, Lacroix R, Judicone C, et al. Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions. Oncotarget 2016 ; 7 : 3357–3366. [CrossRef] [PubMed] [Google Scholar]
  17. Wolf P.. The nature and significance of platelet products in human plasma. Br J Haematol 1967 ; 13 : 269–288. [CrossRef] [PubMed] [Google Scholar]
  18. Lacroix R, Vallier L, Bonifay A, et al. Microvesicles and Cancer Associated Thrombosis. Semin Thromb Hemost 2019 ; 45 : 593–603. [CrossRef] [PubMed] [Google Scholar]
  19. Hisada Y, Mackman N. Measurement of tissue factor activity in extracellular vesicles from human plasma samples. Res Pract Thromb Haemost 2019 ; 3 : 44–48. [CrossRef] [PubMed] [Google Scholar]
  20. Vallier L, Bouriche T, Bonifay A, et al. Increasing the sensitivity of the human microvesicle tissue factor activity assay. Thromb Res 2019 ; 182 : 64–74. [CrossRef] [PubMed] [Google Scholar]
  21. Franco C, Lacroix R, Vallier L, et al. A new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids. Thromb Res 2020; 196 : 414–24. [CrossRef] [PubMed] [Google Scholar]
  22. van Es N, Hisada Y, Di Nisio M, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res 2018 ; 166 : 54–59. [CrossRef] [PubMed] [Google Scholar]
  23. Guervilly C, Bonifay A, Burtey S, et al. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv 2021; 5 : 628–34. [CrossRef] [PubMed] [Google Scholar]
  24. Abels ER, Breakefield XO. Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake. Cell Mol Neurobiol 2016 ; 36 : 301–312. [CrossRef] [PubMed] [Google Scholar]
  25. Manier S, Leleu X, Avet-Loiseau H. Rôle pronostique des microARN des exosomes circulants dans le myélome multiple. Med Sci (Paris) 2017 ; 33 : 939–941. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Laurent LC, Abdel-Mageed AB, Adelson PD, et al. Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles 2015 ; 4 : 26533. [CrossRef] [PubMed] [Google Scholar]
  27. Hill AF, Pegtel DM, Lambertz U, et al. ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J Extracell Vesicles 2013; 2. [PubMed] [Google Scholar]
  28. https://exrna.shinyapps.io/mirdar/. [Google Scholar]
  29. Srinivasan S, Yeri A, Cheah PS, et al. Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation. Cell 2019 ; 177 : 446–62.e16. [CrossRef] [PubMed] [Google Scholar]
  30. Hill AF, Pegtel DM, Lambertz U, et al. ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J Extracell Vesicles 2013; 2. [PubMed] [Google Scholar]
  31. Kappel A, Keller A. miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects. Clin Chem Lab Med 2017 ; 55 : 636–647. [CrossRef] [PubMed] [Google Scholar]
  32. Zarà M, Amadio P, Campodonico J, et al. Exosomes in Cardiovascular Diseases. Diagnostics (Basel) 2020; 10 : E943. [CrossRef] [Google Scholar]
  33. Happel C, Ganguly A, Tagle DA. Extracellular RNAs as potential biomarkers for cancer. J Cancer Metastasis Treat 2020; 6 : 32. [PubMed] [Google Scholar]
  34. Zhou R, Wang L, Zhao G, et al. Circulating exosomal microRNAs as emerging non-invasive clinical biomarkers in heart failure: Mega bio-roles of a nano bio-particle. IUBMB Life 2020; 72 : 2546–62. [CrossRef] [PubMed] [Google Scholar]
  35. Bei Y, Yu P, Cretoiu D, et al. Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases. Adv Exp Med Biol 2017 ; 998 : 71–88. [CrossRef] [PubMed] [Google Scholar]
  36. Bi S, C W, Y J, et al. Correlation between serum exosome derived miR-208a and acute coronary syndrome. Int J Clin Exp Med 2015; 8. [Google Scholar]
  37. Yang Y, Cai Y, Wu G, et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci (Lond) 2015 ; 129 : 675–685. [CrossRef] [PubMed] [Google Scholar]
  38. Margolis E, Brown G, Partin A, et al. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis 2021. https://doi.org/10.1038/s41391-021-00456-8. [PubMed] [Google Scholar]
  39. Singh A, Singh AK, Giri R, et al. The role of microRNA-21 in the onset and progression of cancer. Future Med Chem 2021; 13 : 1885–906. [CrossRef] [PubMed] [Google Scholar]
  40. Dejima H, Iinuma H, Kanaoka R, et al. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer. Oncol Lett 2017 ; 13 : 1256–1263. [CrossRef] [PubMed] [Google Scholar]
  41. Lacroix R, Judicone C, Poncelet P, et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012 ; 10 : 437–446. [CrossRef] [PubMed] [Google Scholar]
  42. Coumans FAW, Brisson AR, Buzas EI, et al. Methodological Guidelines to Study Extracellular Vesicles. Circ Res 2017 ; 120 : 1632–1648. [CrossRef] [PubMed] [Google Scholar]
  43. Brennan K, Martin K, FitzGerald SP, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep 2020; 10 : 1039. [CrossRef] [PubMed] [Google Scholar]
  44. Cointe S, Judicone C, Robert S, et al. Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. J. Thromb. Haemost 2017 ; 15 : 187–193. [CrossRef] [Google Scholar]
  45. Coumans FAW, Brisson AR, Buzas EI, et al. Methodological Guidelines to Study Extracellular Vesicles. Circ Res 2017 ; 120 : 1632–1648. [CrossRef] [PubMed] [Google Scholar]
  46. Marcoux G, Laroche A, Hasse S, et al. Platelet EVs contain an active proteasome involved in protein processingfor antigen presentation via MHC-I molecules. Blood 2021 Jul 22. blood.2020009957. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.